Partners
The company is funded by the Brandon BioCatalyst, which is managed by the life science specialist venture capital management firm Brandon Capital.
Monash University and the University of South Australia are also key shareholders in the company, with technology from the Monash Institute of Pharmaceutical Sciences (MIPS), the Centre for Cancer Biology (CCB) and SA Pathology driving the research program at Cincera.